Objective-To summarise a conference convened to examine how cystic fibrosis
screening might appropriately be introduced into routine prenatal practice
.
Methods-Participant included experts from various relevant disciplines. Sys
tematic reviews and data from individual trials were presented; issues were
identified and discussed.
Results-Judged by published criteria, prenatal cystic fibrosis screening is
suitable for introduction. Screening can be performed cost effectively by
identifying racial/ethnic groups at sufficient risk and then using either o
f two models for delivering laboratory services. Validated educational mate
rials exist. Ethical issues are not unique.
Conclusions-Once adequate facilities for patient and provider education, te
sting, counselling, quality control, and monitoring are in place, individua
l programmes can begin prenatal screening for cystic fibrosis.